Biovyt Pharma Private Limited - Company Profile

It is a healthcare private limited company based in Indore, Madhya Pradesh, India, established in 2021.
2021 Indore, Madhya Pradesh, India Struck Off
Last Updated:
Access Report
About Biovyt Pharma Private Limited

Biovyt Pharma Private Limited, a struck off private limited company, was established on 21 September 2021 in Indore, Madhya Pradesh, India. Engaging in medical equipment retail & distribution within the healthcare sector, it holds CIN: U24290MP2021PTC057549. Registered under ROC Roc Gwalior. it is unlisted. It has an authorized capital of ₹1.50 M and a paid-up capital of ₹0.15 M.

It upholds a compliant status. Its leadership includes Dhiraj Raghuvanshi (Director), Himanshu Choudhary (Director), Vivek Raghuvanshi (Director). It is based at Flat No. 202, 4-E, Aakar Regency, Scheme No.71, Gumasta Nagar, Indore, Madhya Pradesh, 452009.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24290MP2021PTC057549

  • Registration Number

    057549

  • Incorporation Date

    21 September 2021

  • Authorized Capital

    ₹1.50 M

  • Paid-Up Capital

    ₹0.15 M

  • ROC Code

    Roc Gwalior

  • Listing Status

    Unlisted

  • Company Status

    Struck Off

Key Metrics
  • Authorised Capital ₹ 1.50 M
  • Paid Up Capital ₹ 0.15 M
  • Company Age 4 Year, 4 Months
Company report

Biovyt Pharma Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Biovyt Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Biovyt Pharma Private Limited?
Current Directors
Name Designation Appointment Date Status
Dhiraj Raghuvanshi Director 21 Sep 2021 Current
Himanshu Choudhary Director 21 Sep 2021 Current
Vivek Raghuvanshi Director 21 Sep 2021 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Biovyt Pharma.

Enhance accessibility to Biovyt Pharma's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Biovyt Pharma revenue growth over time
Biovyt Pharma profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Biovyt Pharma?

Unlock access to Biovyt Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Biovyt Pharma?

Biovyt Pharma has a workforce of 0 employees as of Mar 29, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Biovyt Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Biovyt Pharma's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Biovyt Pharma
Recent Activity within the Organization
  • Director Appointment

    Progress on Dhiraj Raghuvanshi was appointed as a Director was appointed as a Director on 21 Sep 2021 & has been associated with this company since 4 years 4 months . was documented.

  • Director Appointment

    The activity Himanshu Choudhary was appointed as a Director was appointed as a Director on 21 Sep 2021 & has been associated with this company since 4 years 4 months . was completed.

  • Director Appointment

    Progress on Vivek Raghuvanshi was appointed as a Director was appointed as a Director on 21 Sep 2021 & has been associated with this company since 4 years 4 months . was documented.

  • Company Incorporation

    Progress on Biovyt Pharma Private Limited was registered on 21 Sep 2021 with Roc Gwalior & aged 4 years 4 months as per MCA records. was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Biovyt Pharma Private Limited?

The CIN of Biovyt Pharma Private Limited is U24290MP2021PTC057549.

Where is Biovyt Pharma Private Limited headquartered?

Biovyt Pharma Private Limited is headquartered at Flat No. 202, 4-E, Aakar Regency, Scheme No.71, Gumasta Nagar, Indore, Madhya Pradesh, 452009.

When was Biovyt Pharma Private Limited incorporated?

Biovyt Pharma Private Limited was incorporated on 21 September 2021.

Who are the current directors of Biovyt Pharma Private Limited?

The current directors of Biovyt Pharma Private Limited are

What is the primary industry of Biovyt Pharma Private Limited?

The primary industry of Biovyt Pharma Private Limited is Healthcare.

Is Biovyt Pharma Private Limited a listed company?

Biovyt Pharma Private Limited is unlisted.

What is the capital structure of Biovyt Pharma Private Limited?

The authorized capital of Biovyt Pharma Private Limited is ₹1.50 M, and the paid-up capital is ₹0.15 M.

What is the compliance status of Biovyt Pharma Private Limited?

The compliance status of Biovyt Pharma Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available